AOTI Inc - Oceanside, California-based medical technology firm - Announces plans for an initial public offering on the AIM market in London this month. AOTI says it has a "proprietary therapy for the reduction in hospitalisations and amputations caused by non-healing wounds, particularly diabetic foot ulcers". It is seeking to raise USD25 million for the company in the IPO, which is being led by Peel Hunt LLP as broker and nominated adviser. The shares are expected to start trading on AIM on June 18.

By Tom Waite, Alliance News editor

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.